Compare MLSS & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLSS | NTRB |
|---|---|---|
| Founded | 1989 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1M | 71.7M |
| IPO Year | 1995 | N/A |
| Metric | MLSS | NTRB |
|---|---|---|
| Price | $0.32 | $4.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.00 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 326.3K | 23.5K |
| Earning Date | 11-13-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,929,517.00 | $2,278,321.00 |
| Revenue This Year | $8.95 | $30.17 |
| Revenue Next Year | $7.51 | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.59 | ★ 12.69 |
| 52 Week Low | $0.28 | $3.72 |
| 52 Week High | $1.39 | $11.78 |
| Indicator | MLSS | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 41.64 | 36.45 |
| Support Level | $0.32 | $4.35 |
| Resistance Level | $0.38 | $4.77 |
| Average True Range (ATR) | 0.04 | 0.40 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 20.51 | 14.13 |
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.